BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 783023)

  • 1. [Recent advances in gas chromatography-mass spectrometry (GC-MS): its application to medicine and biology].
    Nihon Yakurigaku Zasshi; 1976; 72(1):1-14. PubMed ID: 783023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mass spectrometry in clinical chemistry].
    Pettersen JE
    Tidsskr Nor Laegeforen; 1977 Oct; 97(29):1508-10, 1513. PubMed ID: 918922
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined use of tandem mass spectrometry with urine gas chromatography/mass spectrometry is useful for diagnosis of inborn errors of metabolism in children].
    Xie LJ; Zhu JX; Zhu XD; Li HJ; Han LS; Gu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):31-4. PubMed ID: 18289467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of gas chromatography/atmospheric pressure chemical ionisation time-of-flight mass spectrometry to impurity identification in Pharmaceutical Development.
    Bristow T; Harrison M; Sims M
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1673-81. PubMed ID: 20486265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-dimensional and comprehensive two-dimensional gas chromatography coupled to soft photo ionization time-of-flight mass spectrometry: a two- and three-dimensional separation approach.
    Welthagen W; Mitschke S; Mühlberger F; Zimmermann R
    J Chromatogr A; 2007 May; 1150(1-2):54-61. PubMed ID: 17418851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry.
    Hasegawa Y; Iga M; Kimura M; Shigematsu Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):13-7. PubMed ID: 15908288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of urine organic acids for the detection of inborn errors of metabolism using urease and gas chromatography-mass spectrometry (GC-MS).
    Lo SF; Young V; Rhead WJ
    Methods Mol Biol; 2010; 603():433-43. PubMed ID: 20077095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search-test in disorders of organic acid metabolism by means of gas chromatography and gas chromatography-mass spectrometry].
    Lehnert W; Niederhoff H
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):474-5. PubMed ID: 876207
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities of using chemical ionization mass spectrometry with ammonia as the selective reaction gas in forensic toxicology].
    Kauert G; Drasch G; von Meyer L
    Beitr Gerichtl Med; 1979; 37():329-35. PubMed ID: 518509
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
    Gopaul SV; Farrell K; Abbott FS
    J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The general toxicology unknown. I. The systematic approach.
    Wu Chen NB; Schaffer MI; Lin RL; Kurland ML; Donoghue ER; Stein RJ
    J Forensic Sci; 1983 Apr; 28(2):391-7. PubMed ID: 6345717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for organic acid disorders.
    Marklová E; Brátová M; Vorísek V
    Acta Medica (Hradec Kralove); 1997; 40(1):17-9. PubMed ID: 9329210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion mobility spectrometry detection for gas chromatography.
    Kanu AB; Hill HH
    J Chromatogr A; 2008 Jan; 1177(1):12-27. PubMed ID: 18067900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing gas chromatography-mass spectrometry to diagnose organic acidemias in Thailand.
    Shotelersuk V; Srivuthana S; Wacharasindhu S; Dhamcharee V; Jaruratanasirikul S; Pangkanon S; Kaewpaluek V; Aroonparkmongkol S
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):566-70. PubMed ID: 11289022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry in clinical chemistry.
    Roboz J
    Adv Clin Chem; 1975; 17():109-91. PubMed ID: 1093361
    [No Abstract]   [Full Text] [Related]  

  • 17. Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].
    De Graeve J
    Ann Biol Clin (Paris); 1978; 36(3):161-8. PubMed ID: 360889
    [No Abstract]   [Full Text] [Related]  

  • 18. The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry.
    de Vries JX; Rudi J; Walter-Sack I; Conradi R
    Biomed Chromatogr; 1990 Jan; 4(1):28-33. PubMed ID: 2310839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry.
    Jones PM; Bennett MJ
    Methods Mol Biol; 2010; 603():423-31. PubMed ID: 20077094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of essential oil components by GC/FTIR and GC/MS].
    Cai JB; Lin P; Sang WQ; Li J; Su QD
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Oct; 25(10):1599-602. PubMed ID: 16395892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.